Floatz logo

Ftbi

Acute-graft-versus-host Disease

Stanford UniversityPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Acute-graft-versus-host Disease cohort.

Asset / SponsorPhaseRating
CARMUSTINE
Stanford University
Phase 2B
Glassia
D

Same molecule, other indications

Ftbi is also rated in:

Hematologic DiseasesDormant
CCC
Indicative ·
53 / 100
View asset →
Non-Hodgkin Lymphoma (NHL)Dormant
CCC
Indicative ·
53 / 100
View asset →
LeukemiaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →